Commercialization Considerations for Cell-Based Therapies: What We Have Learned So Far
Crossref DOI link: https://doi.org/10.1007/s40472-017-0173-6
Published Online: 2017-11-11
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McAllister, Todd
L’Heureux, Nicolas
Atala, Anthony
License valid from 2017-11-11
